Letter to the Editor:
Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis
AIDS Res Hum Retroviruses
.
2021 Jun;37(6):407-408.
doi: 10.1089/AID.2021.0032.
Authors
Mustafa E Ibrahim
1
,
David V Glidden
2
,
Robert M Grant
2
,
Peter L Anderson
1
Affiliations
1
Department of Pharmaceutical Sciences and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
2
University of California San Francisco, San Francisco, California, USA.
PMID:
33913746
PMCID:
PMC8213004
DOI:
10.1089/AID.2021.0032
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Anti-HIV Agents* / therapeutic use
Forgiveness*
HIV Infections* / drug therapy
HIV Infections* / prevention & control
Humans
Pre-Exposure Prophylaxis*
Substances
Anti-HIV Agents
Grants and funding
R01 AI122298/AI/NIAID NIH HHS/United States
UL1 TR001082/TR/NCATS NIH HHS/United States
U01 AI106499/AI/NIAID NIH HHS/United States